Related Experiment Video
Updated: Mar 11, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Resveratrol Inhibited Non-small Cell Lung Cancer Through Inhibiting STAT-3 Signaling
Xin Li1, Dan Wang1, Qing Chun Zhao1
1Department of Lung Cancer Surgery, Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Heping District, Tianjin, China.
Background:
Resveratrol has demonstrated many beneficial effects against cancers; however, the mechanism remains unclear. Non-small cell lung cancer accounts for 80% of lung cancers. The present study was designed to observe the effects and related mechanisms of resveratrol on non-small cell lung cancer in in vitro A549 cells.
Materials And Methods:
The anticancer effects of resveratrol were analyzed on cell viability, migration and invasion, proliferation and apoptosis. Cell viability was determined by sulphorhodamine B assays. Cell proliferation and apoptosis were determined by flow cytometry and migration and invasion by transwell chamber analysis. Expression of STAT-3 was examined by real-time polymerase chain reaction and western blot. Overexpressing vector of STAT-3 was also constructed and transfected into A549 cells to observe the effects of resveratrol on STAT-3 signaling.
Results:
The results showed that resveratrol displayed a dose-dependent and time-dependent cytotoxicity action on A549 cell viability. Resveratrol also inhibited proliferation, migration and invasion and promoted apoptosis in a time-dependent manner from 0-72 hours. Further study showed that resveratrol inhibited the messenger RNA and protein expression of STAT-3, and overexpressed STAT-3 abolished the effects of resveratrol on proliferation, apoptosis, migration and invasion totally or in part.
Conclusions:
These results suggest that the anticancer effects of resveratrol are mediated by STAT-3 signaling.
Insights
Resveratrol exhibits anticancer properties against non-small cell lung cancer by inhibiting STAT-3 signaling. This natural compound reduces cancer cell viability, proliferation, migration, and invasion while promoting apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Resveratrol demonstrates potential anticancer effects, but its precise mechanisms, particularly in non-small cell lung cancer (NSCLC), require elucidation.
- NSCLC represents a significant majority (80%) of all lung cancer cases, highlighting the need for effective therapeutic strategies.
- This study investigates resveratrol's impact on A549 NSCLC cells in vitro.
Purpose of the Study:
- To determine the anticancer effects of resveratrol on non-small cell lung cancer (NSCLC) cell line A549.
- To elucidate the underlying molecular mechanisms, focusing on Signal Transducer and Activator of Transcription 3 (STAT-3) signaling.
- To assess resveratrol's influence on cell viability, proliferation, apoptosis, migration, and invasion.
Main Methods:
- Resveratrol's effects on A549 cell viability were assessed using sulphorhodamine B assays.
- Cell proliferation and apoptosis were quantified via flow cytometry.
- Cell migration and invasion were evaluated using Transwell chamber assays.
- STAT-3 expression (mRNA and protein) was analyzed by real-time PCR and Western blot.
- The functional role of STAT-3 was investigated using STAT-3 overexpressing vectors.
Main Results:
- Resveratrol demonstrated dose- and time-dependent cytotoxicity against A549 cells.
- Resveratrol significantly inhibited proliferation, migration, and invasion, while promoting apoptosis in a time-dependent manner (0-72 hours).
- Resveratrol suppressed both mRNA and protein expression of STAT-3. Overexpression of STAT-3 partially or completely reversed resveratrol's inhibitory effects.
Conclusions:
- The anticancer effects of resveratrol against non-small cell lung cancer cells are mediated through the modulation of STAT-3 signaling.
- Targeting STAT-3 signaling represents a potential therapeutic strategy for NSCLC leveraging resveratrol.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
